SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 76 filers reported holding SERES THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 1.45 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $290,000 | -2.0% | 41,725 | 0.0% | 0.00% | – |
| Q2 2021 | $296,000 | -65.5% | 41,725 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $859,000 | -2.1% | 41,725 | +16.5% | 0.00% | 0.0% |
| Q4 2020 | $877,000 | -1.0% | 35,803 | +14.4% | 0.00% | 0.0% |
| Q3 2020 | $886,000 | +418.1% | 31,303 | +106.3% | 0.00% | – |
| Q1 2017 | $171,000 | 0.0% | 15,170 | -12.2% | 0.00% | – |
| Q4 2016 | $171,000 | -19.3% | 17,270 | 0.0% | 0.00% | – |
| Q3 2016 | $212,000 | -77.1% | 17,270 | -45.8% | 0.00% | -100.0% |
| Q2 2016 | $926,000 | +8.3% | 31,882 | -0.9% | 0.00% | 0.0% |
| Q1 2016 | $855,000 | +63.5% | 32,182 | +116.0% | 0.00% | +100.0% |
| Q4 2015 | $523,000 | +16.0% | 14,900 | -2.0% | 0.00% | 0.0% |
| Q3 2015 | $451,000 | -25.6% | 15,200 | +4.1% | 0.00% | 0.0% |
| Q2 2015 | $606,000 | – | 14,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 21,571,764 | $610,696,000 | 16.87% |
| RA Capital Management | 4,750,000 | $134,473,000 | 2.46% |
| ARK Investment Management | 12,293,033 | $348,016,000 | 2.06% |
| Opaleye Management Inc. | 335,312 | $9,493,000 | 1.86% |
| Sio Capital Management, LLC | 316,800 | $8,969,000 | 1.78% |
| Ikarian Capital, LLC | 762,400 | $21,585,000 | 1.56% |
| Nikko Asset Management Americas, Inc. | 5,531,670 | $152,176,000 | 1.35% |
| EAM Global Investors LLC | 121,629 | $3,443,000 | 1.26% |
| EAM Investors, LLC | 133,591 | $3,782,000 | 0.90% |
| GILDER GAGNON HOWE & CO LLC | 3,185,420 | $90,179,000 | 0.56% |